SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading Is Seer SEER stock nearing key support Seer posts narrower loss beats EPS views by 112 NESR National delivers 235 percent Q4 2025 EPS beat shares gain 347 percent on positive investor sentiment